INVESTIGATING THE ENDOCANNABINOID SYSTEM IN BORDERLINE PERSONALITY DISORDER AND ANTISOCIAL PERSONALITY DISORDER

Registry ID

CAMHPET-CTA-94

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

CENTRE FOR ADDICTION AND MENTAL HEALTH

Start date

2018-01-25

Completion date

2022-02-03

Last update

2015-09-11

Conditions

• PERSONALITY DISORDER

Related clinical trials

• COMBINING KETAMINE WITH DIALECTICAL BEHAVIOURAL THERAPY (DBT) FOR SUICIDALITY IN INDIVIDUALS WITH TREATMENT RESISTANT DEPRESSION AND BORDERLINE PERSONALITY DISORDER: A PHASE II RANDOMIZED, MIDAZOLAM-CONTROLLED CLINICAL TRIAL (KET-DBT)
• TARGETING OPIOID NEUROTRANSMISSION IN BORDERLINE PERSONALITY DISORDER WITH SELF-HARMING BEHAVIOR: A [11C]-NOP-1A POSITRON EMISSION TOMOGRAPHY STUDY

View on source registry